The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

 The acromegaly market has experienced rapid growth in recent years, and the momentum is set to continue. This blog explores the current state of the market, factors driving its expansion, and the major trends shaping its future.

Market Overview

• The acromegaly market size is projected to grow from $1.79 billion in 2023 to $2.15 billion in 2024, reflecting a remarkable CAGR of 19.8%.
• The forecast period anticipates even more substantial growth, reaching $4.17 billion in 2028, with a robust CAGR of 18.1%.

Factors Propelling Growth

1. Hormonal Disease Prevalence

• The surge in hormonal diseases, including diabetes, is a key driver for the acromegaly market.
• Dysfunction in the endocrine system, resulting in conditions like acromegaly, is on the rise globally.

2. Increasing Cases of Diabetes

• Diabetes, a prevalent hormonal disease, affects millions worldwide.
• Overproduction of hormones, such as growth hormone, can lead to conditions like acromegaly, further exacerbating the diabetes epidemic.

3. Growing Insulin Resistance

• About 50% of individuals with acromegaly may develop insulin resistance or type 2 diabetes due to the impact of elevated growth hormone levels.
• The International Diabetes Federation predicts a significant increase in diabetes cases, indirectly contributing to acromegaly prevalence.

Major Players in the Market

• Pfizer Inc.
• Johnson & Johnson Private Limited
• Merck & Co Inc.
• AbbVie Inc.
• Bayer AG
• Novartis AG
• Sanofi S.A.
• AstraZeneca PLC
• GlaxoSmithKline PLC
• Eli Lilly and Company

View More On The Acromegaly Market Report 2023 – https://www.thebusinessresearchcompany.com/report/acromegaly-global-market-report

Innovative Solutions Driving Market Dominance

1. Generic Lanreotide for Acromegaly Treatment

• Advanz Pharma Corp. launched Mytolac (lanreotide), the first generic lanreotide for acromegaly treatment in Germany.
• Lanreotide is recommended for patients with abnormal growth hormone and insulin-like growth factor-1 levels after surgery or other treatments.

2. Xeris Pharmaceuticals Inc. Acquisition

• In September 2021, Xeris Pharmaceuticals Inc. acquired Strongbridge Biopharma PLC.
• This strategic move strengthened Xeris’ endocrinology portfolio, positioning it as an innovator in addressing unmet needs in rare endocrine disorders, including acromegaly.

Market Segmentation

1. Types of Acromegaly

• Ectopic Acromegaly
• Acromegaly Due To Growth Hormone

2. Diagnosis Methods

• GH And IGF-I Measurement
• Growth Hormone Suppression Test
• Imaging
• Other Diagnosis

3. Routes of Administration

• Oral
• Parenteral
• Other Routes Of Administrations

4. Treatment Options

• Medication
• Somatostatin Analogues
• Dopamine Agonists
• Growth Hormone Antagonist
• Surgery
• Radiation
• Other Treatments

5. End Users

• Hospitals
• Specialty Clinics
• Homecare
• Other End Users

Future Trends and Outlook

1. Innovative Treatments

• The forecast period will witness a surge in innovative treatments for acromegaly, offering patients more effective and targeted therapeutic options.

2. Targeted Therapies Development

• Ongoing research and development activities are focusing on the development of targeted therapies for acromegaly, promising advancements in treatment precision.

3. Strong Drug Pipeline

• The acromegaly market boasts a robust pipeline of drugs, indicating a continuous stream of new and improved treatment options.

4. Advances in Treatment Options

• Continued advancements in treatment options, including minimally invasive procedures, will enhance patient outcomes and satisfaction.

5. Advanced Personalized Medicine

• The future of acromegaly treatment will see a shift towards advanced personalized medicine, tailoring interventions to individual patient needs.

Request A Sample Of The Global Acromegaly Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12913&type=smp

The Acromegaly Global Market Report 2023  provides a comprehensive overview on the acromegaly market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –
Central Nervous System Biomarkers Global Market Report 2023
Neurophysiology Devices And Equipment Global Market Report 2023
Generic Central Nervous System Drugs Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model